References
- Yamamoto M, Takahashi H, Shinomura Y. Mechanisma and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol. 2014;10(3):148–59.
- Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, et al. Necessity of early intervention for IgG4-related disease–delayed treatment induces fibrosis progression. Rheumatology (Oxford). 2013; 52(4):679–83.
- Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD),2011. Mod Rheumatol.2012;22(1):21–30.
- Yamamoto M, Takahashi H, Shinomura Y. Mikulicz's disease and the extraglandular lesions. Curr Immunol Rev. 2011;7(2):162–71.
- The Japan Pancreas Society, the Ministry of Health and WelfareInvestigation Research Team for Intractable Pancreatic Disease. Suizo. 2012;27(1):17–25. (In Japanese with English abstract).
- Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15(5):615–26.
- Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis2012. J Hepatobiliary Pancreat Sci. 2012;19(5):539–42.
- Goto H, Takahira M, Azumi A. Japanese study Group for IgG4-Related Ophthalmic Disease. Jpn J Ophthalmol. 2015;59(1):1–7.
- Yamamoto M, Yajima H, Takahashi H, Yokoyama Y, Ishigami K, Shimizu Y, et al. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: results from the SMART database. Mod Rheumatol. 2015;25(2):199–204.